Injection Site Reaction Clinical Trial
Official title:
Prospective, Single Site, Controlled Comparative Study to Identify and Assess Tissue Responses After Injection With Various Biostimulatory Products
The objective of this study is to identify and assess in vivo tissue responses after injection with various biostimulatory products at various timepoints. The study will also provide tissue specimens which will be used in a subsequent study. Safety endpoint: incidence of adverse events.
The objective of this study is to identify and assess tissue responses after injection with various biostimulatory products that are already used in the market and have CE approval. The study will assess in vivo tissue responses and provide tissue specimens which will be used in a subsequent study, under a separate protocol. Assessments under this protocol will include ultrasound of in vivo tissue. Safety endpoint: incidence of adverse events. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05007041 -
Simultaneous RZV and aIIV4 Vaccination
|
Phase 4 | |
| Completed |
NCT05157230 -
Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination
|
N/A | |
| Completed |
NCT05028361 -
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
|
Phase 4 | |
| Completed |
NCT03645369 -
Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection
|
N/A | |
| Completed |
NCT03841396 -
A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.
|
Phase 4 | |
| Recruiting |
NCT04962152 -
Naldebain and Video-assisted Thoracoscopic Surgery
|
Phase 4 | |
| Completed |
NCT03183908 -
FLUAD® vs. Fluzone® High-Dose Study
|
Phase 4 | |
| Recruiting |
NCT05221333 -
Sorrel 25R Injector - Sorrel Clinical Study Protocol
|
N/A | |
| Completed |
NCT05157191 -
Safety of Pediatric COVID-19 Vaccination
|